Antibiotic Use Among Residents Receiving Skilled Nursing Care in 29 U.S. Nursing Homes.


Journal

Journal of the American Geriatrics Society
ISSN: 1532-5415
Titre abrégé: J Am Geriatr Soc
Pays: United States
ID NLM: 7503062

Informations de publication

Date de publication:
02 2021
Historique:
received: 16 06 2020
revised: 31 08 2020
accepted: 10 09 2020
pubmed: 11 10 2020
medline: 18 9 2021
entrez: 10 10 2020
Statut: ppublish

Résumé

Data describing antibiotic use in U.S. nursing homes remain limited. We report antibiotic use among skilled nursing facility residents from 29 U.S. nursing homes and assessed correlations between antibiotics prescribed to residents in skilled care and nursing home characteristics. Retrospective cohort study. Twenty-nine U.S. nursing homes in the same healthcare corporation. Residents receiving skilled care in 2016. We used pharmacy invoice and nursing home census data to calculate the days of antibiotic therapy per 1,000 days of skilled care (1,000 DOSC), the rate of antibiotic starts per 1,000 DOSC, the length of antibiotic therapy, and the average antibiotic spectrum index. We also assessed correlations between antibiotic use and nursing home characteristics. Antibiotics accounted for an average of 9.6% (±0.6%) of systemic medications prescribed among residents receiving skilled care. On average, 26.8% (±2.9%) of antibiotics were intravenous. Fluoroquinolones were prescribed at the highest rates (19% across all facilities), followed by beta-lactam/beta-lactamase inhibitors (11%), first- and second-generation cephalosporins, sulfonamides, and oral tetracyclines (each at 9%). Both the proportion of residents using enrolled in Medicare and number of unique prescribers responsible for systemic prescriptions positively correlated with the rate of antibiotic starts. Our study demonstrates that pharmacy invoices represent a useful and preexisting source of data for assessing antibiotic prescriptions among individuals receiving skilled nursing care. The correlation between the number of unique prescribers and antibiotic starts suggests that prescribers are central to efforts to improve antibiotic use in nursing homes.

Sections du résumé

BACKGROUND
Data describing antibiotic use in U.S. nursing homes remain limited. We report antibiotic use among skilled nursing facility residents from 29 U.S. nursing homes and assessed correlations between antibiotics prescribed to residents in skilled care and nursing home characteristics.
DESIGN
Retrospective cohort study.
SETTING
Twenty-nine U.S. nursing homes in the same healthcare corporation.
PARTICIPANTS
Residents receiving skilled care in 2016.
MEASUREMENTS
We used pharmacy invoice and nursing home census data to calculate the days of antibiotic therapy per 1,000 days of skilled care (1,000 DOSC), the rate of antibiotic starts per 1,000 DOSC, the length of antibiotic therapy, and the average antibiotic spectrum index. We also assessed correlations between antibiotic use and nursing home characteristics.
RESULTS
Antibiotics accounted for an average of 9.6% (±0.6%) of systemic medications prescribed among residents receiving skilled care. On average, 26.8% (±2.9%) of antibiotics were intravenous. Fluoroquinolones were prescribed at the highest rates (19% across all facilities), followed by beta-lactam/beta-lactamase inhibitors (11%), first- and second-generation cephalosporins, sulfonamides, and oral tetracyclines (each at 9%). Both the proportion of residents using enrolled in Medicare and number of unique prescribers responsible for systemic prescriptions positively correlated with the rate of antibiotic starts.
CONCLUSIONS
Our study demonstrates that pharmacy invoices represent a useful and preexisting source of data for assessing antibiotic prescriptions among individuals receiving skilled nursing care. The correlation between the number of unique prescribers and antibiotic starts suggests that prescribers are central to efforts to improve antibiotic use in nursing homes.

Identifiants

pubmed: 33037613
doi: 10.1111/jgs.16856
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-406

Informations de copyright

© 2020 The American Geriatrics Society.

Références

Nicolle LE, Bentley DW, Garibaldi R, Neuhaus EG, Smith PW. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol. 2000;21:537-545.
Threat report 2013 antimicrobial resistance | CDC. http://www.cdc.gov/drugresistance/threat-report-2013/index.html. Accessed October 20, 2013.
Obama B. Executive Order - Combating Antibiotic-Resistant Bacteria. 2014. https://www.whitehouse.gov/the-press-office/2014/09/18/executive-order-combating-antibiotic-resistant-bacteria. Accessed August 29, 2015.
The Joint Commission. R3 report issue 23 antimicrobial stewardship in ambulatory health care. https://www.jointcommission.org/standards/r3-report/. Accessed April 29, 2020.
Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62:e51-e77.
Katz MJ, Gurses AP, Tamma PD, Cosgrove SE, Miller MA, Jump RLP. Implementing antimicrobial stewardship in long-term care settings: an integrative review using a human factors approach. Clin Infect Dis. 2017;65:1943-1951.
Pakyz AL, Dwyer LL. Prevalence of antimicrobial use among United States nursing home residents: results from a national survey. Infect Control Hosp Epidemiol. 2010;31:661-662.
The Center for Medicare and Medicaid Services (CMS). Medicare and Medicaid programs; reform of requirements for long-term care facilities. 2016. https://www.federalregister.gov/documents/2016/10/04/2016-23503/medicare-and-medicaid-programs-reform-of-requirements-for-long-term-care-facilities. Accessed November 8, 2016.
The Center for Medicare and Medicaid Services (CMS). Medicare state operations manual, appendix PP: interpretive guidelines for long-term care facilities. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Internet-Only-Manuals-IOMs-Items/CMS1201984.html. Accessed March 3, 2020.
The core elements of antibiotic stewardship for nursing homes. Nursing homes and assisted living (LTC) | CDC. http://www.cdc.gov/longtermcare/prevention/antibiotic-stewardship.html. Accessed June 25, 2016.
Davidson HE, Jump RLP. Challenges in tracking and reporting antibiotic use in long-term care. J Am Med Direct Assoc. 2020;21:1191-1196.
Crnich CJ, Jump R, Trautner B, Sloane PD, Mody L. Optimizing antibiotic stewardship in nursing homes: a narrative review and recommendations for improvement. Drugs Aging. 2015;32:699-716.
Carter R, Montpetite M, Jump RLPA. mixed-methods pilot study to assess perceptions of antimicrobial stewardship in nursing homes. J Am Geriatr Soc. 2017;65:1073-1078.
Medicare.gov Nursing Home Compare. https://www.medicare.gov/nursinghomecompare/search.html. Accessed June 27, 2014.
Long-term care: facts on care in the US - LTCFocus.org. http://www.ltcfocus.org/. Accessed November 25, 2019.
Center for Medicare and Medicaid Services. Health care & prescriptions in a nursing home. Medicare. https://www.medicare.gov/what-medicare-covers/what-part-a-covers/health-care-prescriptions-in-a-nursing-home. Accessed April 28, 2020.
Gerber JS, Hersh AL, Kronman MP, Newland JG, Ross RK, Metjian TA. Development and application of an antibiotic spectrum index for benchmarking antibiotic selection patterns across hospitals. Infect Control Hosp Epidemiol. 2017;38:993-997.
R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2017. http://www.R-project.org/.
Pohlert T. Trend: non-parametric trend tests and change-point detection. 2018. https://CRAN.R-project.org/package=trend. Accessed October 24, 2019.
Thompson ND, LaPlace L, Epstein L, et al. Prevalence of antimicrobial use and opportunities to improve prescribing practices in U.S. nursing homes. J Am Med Dir Assoc. 2016;17:1151-1153.
Daneman N, Gruneir A, Bronskill SE, et al. Prolonged antibiotic treatment in long-term care: role of the prescriber. JAMA Intern Med. 2013;173:673-682.
Jump RLP, Olds DM, Seifi N, et al. Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use. Infect Control Hosp Epidemiol. 2012;33:1185-1192.
National Center for Health Statistics. Data access - urban rural classification scheme for counties. 2019. https://www.cdc.gov/nchs/data_access/urban_rural.htm. Accessed June 1, 2020.
Lepore M, Leland NE. Nursing homes that increased the proportion of Medicare days achieved gains in quality. Health Aff (Millwood). 2015;34:2121-2128.
Phillips CD, Adepoju O, Stone N, et al. Asymptomatic bacteriuria, antibiotic use, and suspected urinary tract infections in four nursing homes. BMC Geriatr. 2012;12:73.
Loeb M, Bentley DW, Bradley S, et al. Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol. 2001;22:120-124.
Jump RLP, Gaur S, Katz MJ, et al. Template for an antibiotic stewardship policy for post-acute and long-term care settings. J Am Med Dir Assoc. 2017;18:913-920.
Mylotte JM. Measuring antibiotic use in a long-term care facility. Am J Infect Control. 1996;24:174-179.
Benoit SR, Nsa W, Richards CL, et al. Factors associated with antimicrobial use in nursing homes: a multilevel model. J Am Geriatr Soc. 2008;56:2039-2044.
Thompson ND, Penna A, Eure TR, et al. Epidemiology of antibiotic use for urinary tract infection in nursing home residents. J Am Med Dir Assoc. 2020;21:91-96.
Roukens M, Verhoef L, Stobberingh E, Natsch S. Surveillance of antimicrobial use in Dutch long-term care facilities. J Antimicrob Chemother. 2017;72:1516-1520.
Stepan D, Ušaj L, Petek Šter M, Smolinger Galun M, Smole H, Beović B. Antimicrobial prescribing in long-term care facilities: a nationwide point-prevalence study, Slovenia, 2016. Euro Surveill. 2018;23. doi:10.2807/1560-7917.ES.2018.23.46.1800100. https://pubmed.ncbi.nlm.nih.gov/30458914/
Daneman N, Campitelli MA, Giannakeas V, et al. Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities. CMAJ. 2017;189:E851-E860.
Charani E, Castro-Sanchez E, Sevdalis N, et al. Understanding the determinants of antimicrobial prescribing within hospitals: the role of “prescribing etiquette.”. Clin Infect Dis. 2013;57:188-196.
Food and Drug Administration. FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. 2019. http://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics. Accessed June 11, 2019.
Maslow JN, Lee B, Lautenbach E. Fluoroquinolone-resistant Escherichia coli carriage in long-term care facility. Emerg Infect Dis. 2005;11:889-894.
Strazzulla A, Bokobza S, Ombandza E, et al. Impact of an antimicrobial stewardship program on resistance to fluoroquinolones of urinary enterobacteriaceae isolated from nursing home residents: a retrospective cohort study. J Am Med Dir Assoc. 2020;21:1322-1326.
Felsen CB, Dodds Ashley ES, Barney GR, et al. Reducing fluoroquinolone use and Clostridioides difficile infections in community nursing homes through hospital-nursing home collaboration. J Am Med Dir Assoc. 2020;21:55-61.e2.
Kabbani S, Palms DL, Bartoces M, et al. Potential utility of pharmacy data to measure antibiotic use in nursing homes. Infect Control Hosp Epidemiol. 2019;40:819-820.
Harris-Kojetin L, Sengupta M, Park-Lee E, et al. Long-term care providers and services users in the United States: data from the national study of long-term care providers, 2013-2014. Vital Health Stat 3. 2016;x-xii:1-105.
Finney JW, Humphreys K, Kivlahan DR, Harris AHS. Why health care process performance measures can have different relationships to outcomes for patients and hospitals: understanding the ecological fallacy. Am J Public Health. 2011;101:1635-1642.

Auteurs

Sunah Song (S)

Cleveland Institute for Computational Biology, Cleveland, Ohio, USA.
Department of Computer and Data Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

Brigid M Wilson (BM)

Division of Infectious Diseases & HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Geriatric Research Education and Clinical Center (GRECC) at the VA Northeast Ohio Healthcare System, Cleveland, Ohio, USA.

Taissa Bej (T)

Geriatric Research Education and Clinical Center (GRECC) at the VA Northeast Ohio Healthcare System, Cleveland, Ohio, USA.

Stefan Gravenstein (S)

Brown University Alpert Medical School and School of Public Health, Brown University, Providence, Rhode Island, USA.
Providence VA Medical Center, Providence, Rhode Island, USA.

Rebecca R Carter (RR)

Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Center for the Advancement of Team Science, Analytics, and Systems Thinking, Ohio State University College of Medicine, Columbus, Ohio, USA.

Joseph Marek (J)

CommuniCare Health Services, Cincinnati, Ohio, USA.

Robin L P Jump (RLP)

Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Division of Infectious Diseases & HIV Medicine, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Geriatric Research Education and Clinical Center (GRECC) at the VA Northeast Ohio Healthcare System, Cleveland, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH